SYMPTOMATIC IMPROVEMENT OBSERVED WITHIN 2 DAYS OF ETRASIMOD INDUCTION THERAPY: RESULTS FROM ELEVATE UC 52 AND ELEVATE UC 12 STUDIES IN PATIENTS WITH ULCERATIVE COLITIS

Marla C. Dubinsky  ¹     Severine Vermeire  ²     María Chaparro  ^{3, 4, 5}     Peter Irving  ⁶     Lauren Bartolome  ⁷     John C. Woolcott  ⁸     Christopher J. Rabbat  ⁸     Wenjin Wang  ⁸     Martina Goetsch  ⁹     Joana Torres  ^{10, 11, 12}     Remo Panaccione  ^13    
1 Icahn School of Medicine at Mount Sinai, New York, United States
² University Hospitals Leuven, Leuven, Belgium
³ Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS Princesa), Madrid, Spain
⁴ Universidad Autónoma de Madrid (UAM), Madrid, Spain
⁵ Centro de Investigacíon Biomédica en Red de Enfermedades Hepáticas y Digestivas
⁶ Guy´s and St Thomas´ NHS Foundation Trust, London, United Kingdom
⁷ Pfizer Inc, New York, United States
⁸ Pfizer Inc, Collegeville, United States
⁹ Pfizer AG, Zürich, Switzerland
¹⁰ Hospital Beatriz Ângelo, Loures, Portugal
¹¹ Hospital da Luz, Lisbon, Portugal
¹² Universidade de Lisboa, Lisbon, Portugal
¹³ University of Calgary, Calgary, Canada

Topic
IBD

Session
Meet the giants at the poster (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)